Table 1 PD patient and control demographics

Sample size

63

61

–

Sex (% male)

51%

66%

0.105

Age at visit

67.5 (7.2)

67.4 (7.1)

0.957

CMV (% positive)

44%

48%

0.719

EBV (% positive)

92%

85%

0.267

ACE-III

94.1 (7.4)

93.0 (4.5)

0.011*

Disease duration (years)

–

0.97 (0.54)

–

MDS-UPDRS-III (motor score)

–

27.8 (10.3)

–

MDS-UPDRS total

–

47.4 (15.1)

–

Levodopa equivalent daily-dose (LEDD)

–

290 (163.5)

–